NCT02041468 Study to Evaluate Resistance Mechanisms and Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients Status UNKNOWN Phase N/A
NCT02041273 Relative Bioavailability Of Palbociclib (PD-0332991) Under Fed And Fasted Conditions Status COMPLETED Phase PHASE1
NCT02040857 Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer Status COMPLETED Phase PHASE2
NCT02039336 Dacomitinib Plus PD-0325901 in Advanced KRAS Mutant NSCLC Status COMPLETED Phase PHASE1/PHASE2
NCT02038777 A Study Of PF-04449913 In Japanese Patients With Select Hematologic Malignancies Status COMPLETED Phase PHASE1
NCT02038764 A Study To Assess The Safety Of PF-06342674 In Adults With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT02036515 Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2) Status COMPLETED Phase PHASE3
NCT02034981 Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK, MET or ROS1 Status COMPLETED Phase PHASE2
NCT02034916 A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study) Status TERMINATED Phase PHASE2
NCT02034877 13-valent Pneumococcal Conjugate Vaccine Study in Adults and Children in India Status COMPLETED Phase PHASE4
NCT02034591 Phase 1 Oral Solution and Crushed Tablet Relative Bioavailability Study of Apixaban When Administered Through a Nasogastric Tube in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02034578 Phase 1 Oral Solution Bioavailability Study of Apixaban When Administered Through a Nasogastric Tube in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02034565 Phase 1 Bioavailability Study of Apixaban Solution Formulation Relative to Apixaban Tablets in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02033889 A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007). Status COMPLETED Phase PHASE3
NCT02031991 A Pharmacokinetic Study Comparing PF-06439535 And Bevacizumab In Healthy Male Volunteers (REFLECTIONS B739-01) Status COMPLETED Phase PHASE1
NCT02030483 Palbociclib in Combination With Lenalidomide and Dexamethasone for Multiple Myeloma Status TERMINATED Phase PHASE1
NCT02028507 Phase III Palbociclib With Endocrine Therapy vs. Capecitabine in HR+/HER2- MBC With Resistance to Aromatase Inhibitors Status COMPLETED Phase PHASE3
NCT02019576 Stereotactic Radiotherapy for Metastatic Kidney Cancer Being Treated With Sunitinib Status COMPLETED Phase PHASE2
NCT02015156 A Study Evaluating The Safety Of PF-05280014 And Trastuzumab In Healthy Male Volunteers (REFLECTIONS B327-06) Status COMPLETED Phase PHASE1